WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR May 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: MAY ISSUE PUBLISHED

    MAY 2024 Issue has been successfully launched on MAY 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

CLINICOPATHOLOGICAL ASSESSMENT OF KIDNEY TUMORS IN SAMPLE OF ADULT IRAQI PATIENTS

*Dr. Rafal Abbas Hussein and Dr. Ban Jumaah Qasim

ABSTRACT

Introduction: Kidney neoplasms are benign and malignant. Renal cell carcinoma (RCC), the worst urologic malignancy, accounting for 2% to 3% of adult malignant neoplasms. Adults develop RCC. More than 90% of RCC cases are clear cell, papillary, or chromophobe, and the male-to-female ratio of adult RCC is 2:1. Adult benign kidney neoplasms vary in histology and clinicobiology. Imaging shows most benign kidney tumours as solid enhancing masses, similar to RCCs. To evaluate the histological diagnosis of kidney tumours in adult Iraqi patients in connection to clinicopathological factors (Age, Gender, Associated clinical symptoms, Size, Side, Site, Gross discovery, Tumour histopathological subtypes, Grade, and pathological stage). Method: The Teaching Laboratory of Al-Imamain Al-Kadhimain Medical City, Pathology Departments of Ghazi Al-Harreri Surgical Specialties Hospital, and private laboratories collected 100 randomly selected kidney tumour patients from January 2019 to May 2022 for a retrospective study. Histopathological reports and slides were gathered and retrospectively analysed for each patient. Patient admission case sheets and pathology reports included clinical information such as age, gender, related clinical characteristics, size, side, location, gross discovery, tumour subtypes, grade, and stage. The data were statistically analysed using SPSS version 23 using CHI square test at 0.05 to determine association associations. Results: The study included a sample aged 18-80 years (mean 52.2 ± 12.2 SD), with a male to female ratio of 1.5:1. The majority of tumors were malignant (91%), with clear cell carcinoma as the most common type (66%). The tumor size ranged from 1.5-20.0 cm (mean 6.3 ± 3.3 SD), and most were

[Full Text Article] [Download Certificate]